Auxilium Inks $657M Deal For Erectile Dysfunction Drug Co.
Auxilium said it made an upfront cash payment of $585 million to Actient stakeholders. The deal also additional Auxilium stock options worth a combined $22.3 million and contingent payments of up to $50 million based on future revenue targets.
The Illinois firm was founded in March...
To view the full article, register now.